Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Grampp

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and InsulinsStella Stergiopoulos, Carrie A Brown, Gustavo Grampp, et al.
Drug Safety|September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare ProfessionalsStella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Expert Opinion on Drug Safety|January 6, 2015
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilarsGustavo Grampp, Machaon Bonafede, Thomas Felix, et al.
Food and Drug Law Journal|February 1, 2014
Global regulatory standards for the approval of biosimilarsBarbara Mounho, Audrey Phillips, Kay Holcombe, et al.
Biotechnology Progress|November 28, 2023
Managing integrated continuous bioprocesses in real time: Deviations in product qualityGustavo Grampp, Allen Bosley, Maen Qadan, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Identifying and Quantifying the Accuracy of Product Name Attribution of US-Sourced Adverse Event Reports in MedWatch of Somatropins and InsulinsStella Stergiopoulos, Carrie A Brown, Gustavo Grampp, et al.
Drug Safety|September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare ProfessionalsStella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Expert Opinion on Drug Safety|January 6, 2015
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilarsGustavo Grampp, Machaon Bonafede, Thomas Felix, et al.
Food and Drug Law Journal|February 1, 2014
Global regulatory standards for the approval of biosimilarsBarbara Mounho, Audrey Phillips, Kay Holcombe, et al.
Biotechnology Progress|November 28, 2023
Managing integrated continuous bioprocesses in real time: Deviations in product qualityGustavo Grampp, Allen Bosley, Maen Qadan, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 2